Angene Chemical
Draw
|
Currency :
Home Products

AG00BC9X

27912-14-7 | Levobunolol hydrochloride

Chemical structure of Levobunolol hydrochloride, CAS 27912-14-7
AG00BC9X
sdsSDS
sdsCOA

Price

$0.00

Add to Cart
WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 27912-14-7
Catalog Number AG00BC9X(AGN-PC-0R3KX7)
Chemical Name Levobunolol hydrochloride
EC Number 248-725-3
IUPAC Name 5-[(2S)-3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydro-2H-naphthalen-1-one;hydrochloride
InChI InChI=1S/C17H25NO3.ClH/c1-17(2,3)18-10-12(19)11-21-16-9-5-6-13-14(16)7-4-8-15(13)20;/h5-6,9,12,18-19H,4,7-8,10-11H2,1-3H3;1H/t12-;/m0./s1
InChI Key DNTDOBSIBZKFCP-YDALLXLXSA-N
MDL Number MFCD03425587
Molecular Formula C17H26ClNO3
Molecular Weight 327.8462
SMILES CC(C)(C)NC[C@@H](COc1cccc2c1CCCC2=O)O.Cl
UNII O90S49LDHH
Synonyms
AKBeta, Apo Levobunolol, Apo-Levobunolol, ApoLevobunolol, Betagan, Levobunolol, Levobunolol Hydrochloride, Novo Levobunolol, Novo-Levobunolol, NovoLevobunolol, PMS Levobunolol, PMS-Levobunolol, PMSLevobunolol, ratio Levobunolol, ratio-Levobunolol, Ultracortenol, Vistagan, W 7000A, W-7000A, W7000A, levobunolol hydrochloride, Levobunolol (hydrochloride), Levobunolol HCl, Betagan, Levobunolol.HCl, 27912-14-7, Gotensin, Vistagan, Akbeta, (-) -Levobunolol hydrochloride, l-Bunolol hydrochloride, CHEBI:6439, UNII-O90S49LDHH, l-Bunolol, DSSTox_CID_777, EINECS 248-725-3, W 7000A, (-)-3,4-Dihydro-5-(3-(tert-butylamino)-2-hydroxypropoxy)-1(2H)-naphthalenone hydrochloride, (-)-5-(3-(tert-Butylamino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone hydrochloride, DSSTox_RID_75784, DSSTox_GSID_20777, O90S49LDHH, 5-({(2S)-3-[(1,1-dimethylethyl)amino]-2-hydroxypropyl}oxy)-3,4-dihydronaphthalen-1(2H)-one hydrochloride, W-7000A, C17H25NO3.HCl, NCGC00016801-01, CAS-27912-14-7, ent-Levobunolol,Hydrochloride, Levobunolol hydrochloride [USAN], Prestwick_167, Betagan (TN), (S)-5-[3-[(1,1-Dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydro-1(2H)-naphthalenone, AC1NR4EJ, (-)-5-(3-(tert-Butylamino)-2-hydroxypropoxy)-3,4-dihydronaphthalene-1(2H)-one hydrochloride, 1(2H)-Naphthalenone, 3,4-dihydro-5-(3-(tert-butylamino)-2-hydroxypropoxy)-, hydrochloride, (-)-, 1(2H)-Naphthalenone, 5-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-, hydrochloride, (-)-, Levobunolol, Hydrochloride, levobunolol monohydrochloride, SCHEMBL42262, MLS002154030, CHEMBL1201177, DTXSID6020777, CTK8G0556, DNTDOBSIBZKFCP-YDALLXLXSA-N, HMS1570J15, HY-B1035, Tox21_110617, Levobunolol hydrochloride (JAN/USP), AKOS030526127, Tox21_110617_1, CCG-220847, CS-4554, LS-7472, W 6421A, ACM27867056, NCGC00016801-05, AN-15275, SMR001233357, D01025, UNII-W0Q9J8634Z component DNTDOBSIBZKFCP-YDALLXLXSA-N, 5-[(2S)-3-(tert-butylamino)-2-hydroxy-propoxy]tetralin-1-one hydrochloride, 5-[(2S)-3-[(1,1-Dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydro-1(2H)-naphthalenone, 5-{[3-(tert-butylamino)-2-hydroxypropyl]oxy}-3,4-dihydronaphthalen-1(2H)-one hydrochloride, (2S)-N-(tert-butyl)-2-hydroxy-3-[(5-oxo-5,6,7,8-tetrahydronaphthalen-1-yl)oxy]propan-1-aminium chloride, 1(2H)-Naphthalenone, 3,4-dihydro-5-(3-(tert-butylamino)-2-hydroxypropoxy)-, hydrochloride,(-)-, 5-[(2S)-3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydro-2H-naphthalen-1-one hydrochloride, 5-[(2S)-3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydronaphthalen-1(2H)-one hydrochloride, Bunolol hydrochloride, (-)-Bunolol, C17H25NO3.ClH, (-)-Levobunolol hydrochloride, C17-H25-N-O3.Cl-H, Levobunolol hydrochloride [USAN:USP], CID5284409, 47141-42-4, (-)-5-[3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydronaphthalene-1(2H)-one hydrochloride, 1(2H)-Naphthalenone, 5-[(2S)-3-[(1,1-dimethylethyl) amino]-2-hydroxypropoxy]-3,4-dihydro-, hydrochloride, 27867-05-6,

Related Research Chemicals

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited